Infections Caused by ESbL-Producing Enterobacteriaceae in Italy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00404625|
Recruitment Status : Unknown
Verified November 2006 by University of Siena.
Recruitment status was: Recruiting
First Posted : November 29, 2006
Last Update Posted : November 29, 2006
To assess the molecular epidemiology, clinical impact, treatment outcome and risk factors for infections caused by Enterobacteriaceae producing ESBLs in Italy in a large multicenter observational survey.
- To collect consecutive nonreplicate isolates of Enterobacteriaceae resistant to expanded-spectrum cephalosporins from clinical specimens from inpatients and outpatients.
- To characterize the isolates for resistance phenotypes and for β-lactam resistance mechanisms.
- To investigate the clonality of isolates.
- To analyse the epidemiology of various resistance mechanisms/resistant clones.
- To collect clinical and epidemiological data for patients with infections caused by the ESBL producers.
- To analyse the epidemiology, risk factors and outcome for infections caused by ESBL producers.
|Condition or disease||Intervention/treatment|
|Enterobacteriaceae Infections Bacteremia Pneumonia Skin Diseases Urinary Tract Infections||Behavioral: Risk factors for infections due to ESBL+ Enterobacteriaceae Behavioral: Risk factors for inadequate initial antimicrobial therapy Behavioral: Overall and 30-day mortality in bad first antibiotic therapy|
Show Detailed Description
|Study Type :||Observational|
|Enrollment :||813 participants|
|Observational Model:||Case Control|
|Official Title:||Infections Caused by Enterobacteriaceae Producing Extended-Spectrum β-Lactamases in Italy: Molecular Epidemiology, Clinical Impact, Treatment Outcome and Risk Factors|
|Study Start Date :||October 2006|
|Study Completion Date :||November 2006|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00404625
|Contact: Gian Maria Rossolini, professore||+39 0577 email@example.com|
|Università Politecnica delle Marche||Recruiting|
|Ancona, Italy, 60100|
|Contact: Giorgio Scalise, MD|
|A.O. “Ospedali Riuniti di Bergamo”||Recruiting|
|Bergamo, Italy, 24128|
|Contact: Fredy Suter, MD|
|Univeristà di Firenze, Ospedale Careggi||Recruiting|
|Firenze, Italy, 50134|
|Contact: Franco Paradisi, Professore|
|Ospedale Niguarda Ca' Granda||Recruiting|
|Milano, Italy, 20159|
|Contact: Liliana Caggese, MD|
|Università Cattolica S. Cuore, Policlinico Gemelli||Recruiting|
|Roma, Italy, 00168|
|Contact: Roberto Cauda, Professore|
|Principal Investigator: Evelina Tacconelli, MD|
|Università di Varese||Recruiting|
|Varese, Italy, 21100|
|Contact: Paolo Grossi, MD|
|Study Chair:||Gian Maria Rossolini, professore||Università di Siena|